Molecular Subtyping for Prognosis Evaluation in Resected Pancreatic Adenocarcinoma

计划入组 226 人 · 首次发布于 2022 年 8 月 2 日

Platelet Transfusion Refractoriness

计划入组 50 人 · 首次发布于 2022 年 6 月 1 日

Human Leukocyte Antigen (HLA) Class I Haplotype Mismatched Natural Killer Cell Infusions

计划入组 13 人 · 首次发布于 2008 年 4 月 17 日

LTCR-O1-1

anti-NY-ESO-1 TCR T-cell therapy siTCR (Takara Bio)

LTCR-N1-1

Universitetet i Oslo

Norway

I-SHOU UNIVERSITY

Taiwan

i-SENS, Inc.

South Korea

T-Neuro Pharma Expands Alzheimer's Blood Biomarker Assay to Include All Patients

ACCESS Trial Shows Promising Survival Rates with PTCy GVHD Prophylaxis in HLA-Mismatched Transplants

Applied StemCell Launches Hypoimmunogenic hiPSC Products to Advance Allogeneic Cell Therapy Development